Competition Law and Policy in the Japanese Pharmaceutical Sector (Kobe University Monograph Series in Social Science Research) - Image 1

£99.71

Springer Competition Law and Policy in the Japanese Pharmaceutical Sector (Kobe University Monograph Series in Social Science Research)

Name: Competition Law and Policy in the Japanese Pharmaceutical Sector (Kobe University Monograph Series in Social Science Research)
Brand: Springer
Price: 104.8 GBP
Availability: InStock

Economics

Price History & Forecast

Last 85 days • 85 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 85 days • 4 price levels

Days at Price

Current Price

Price Analysis

Most common price: £105 (44 days, 51.8%)

Price range: £100 - £105

Price levels: 4 different prices over 85 days

Description

This is the first book published that focuses on competition law and policy in the Japanese pharmaceutical sector. It consists of chapters written and edited by academics who research the industry from various perspectives, including economics, competition law, pharmaceutical regulations, and intellectual property law. Competition policies involving pharmaceutical products attract attention from academics and policymakers worldwide. The pharmaceutical industry is regulated by drug laws that vary from country to country and are affected by differing practices and industrial structures. The book begins by examining drug regulations and trade practices in the industry that are peculiar to Japan and its healthcare system. It then presents the Japanese Antimonopoly Act and cases involving it, and discussions of current competition law issues in the Japanese pharmaceutical industry. The book also discusses innovation and intellectual property and economic analyses of pharmaceutical regulations and drug discovery. The chapters include comparative studies on Japanese regulations vs. those in the European Union and the United States. Japan is one of the biggest pharmaceutical markets in the world. With this in mind, the book provides “one-stop shopping” for anyone interested in pharmaceutical regulations in the country. Covering the basics but extending to in-depth explorations of complex problems, this book appeals not only to students and academics, pharmaceutical companies and regulators, but also to those dealing with real-world policy issues that encompass competition policy, intellectual property, and pharmaceutical regulation. Chapter 11 is available open access under a Creative Commons Attribution 4.0 International License via link.springer.com

Product Specifications

Brand: Springer
Format: paperback
ASIN: 9811678162
Category: Books > Subjects > Business, Finance & Law > Economics
Domain: Amazon UK
Release Date: 10 February 2023
Listed Since: 13 January 2023

Barcode

No barcode data available

Springer Competition Law and Policy in the Japanese Pharmaceutical Sector (Kobe University Monograph Series in Social Science Research)

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Boosting Pharmaceutical Innovation in the Post-TRIPS Era: Real-Life Lessons for the Developing World

Das europäische Arzneimittelrecht: Zentrale Rechtsfragen des Arzneimittelzulassungsverfahrens

Global Issues in Pharmaceutical Marketing

Intellectual Property, Pharmaceuticals and Public Health: Access to Drugs in Developing Countries

The Public Financing of Pharmaceuticals: An Economic Approach

Optimization of Pharmaceutical R&D Programs and Portfolios: Design and Investment Strategy

Equitable Access to High-Cost Pharmaceuticals

Counterfeit and Falsified Medicines in the EU: A Legal Perspective (Elgar Studies in Health and the Law)

Pharmaceutical Innovation: Incentives, Competition, and Cost-Benefit Analysis in International Perspective

The Politics of the Pharmaceutical Industry and Access to Medicines: World Pharmacy and India

Drug Information: A Guide for Pharmacists, Fourth Edition

Kommunikations-Strategien im Pharma-Markt: Verhaltenswissenschaftliche Ansätze zur Ärzte- und Patienten-Ansprache im Markt für verschreibungspflichtige Präparate: 35 (Konsum und Verhalten, 35)

Pharmaceutical Statistics: MBSW 39, Muncie, Indiana, USA, May 16-18, 2016: 218 (Springer Proceedings in Mathematics & Statistics, 218)

Drug Control and International Law (Routledge Research in International Law)

Pharmaceutical Care in Digital Revolution: Blending Digital with Human Innovation

Global Pharmaceutical Policy

Pharmaceutical Test Data Exclusivity: A Multi-Jurisdictional Survey (AIPPI Law, 7)

A Human Rights Framework for Intellectual Property, Innovation and Access to Medicines

Databases for Pharmacoepidemiological Research (Springer Series on Epidemiology and Public Health)

Defining Drugs: How Government Became the Arbiter of Pharmaceutical Fact

Converging Pharmacy Science and Engineering in Computational Drug Discovery (Advances in Healthcare Information Systems and Administration)

Competition Policy: An Empirical and Economic Approach

Quality Control of Pharmaceuticals: Compendial Standards and Specifications

Theory of Drug Development: 61 (Chapman & Hall/CRC Biostatistics Series)